Cargando…

Radiotherapeutic Strategies to Overcome Resistance of Breast Cancer Brain Metastases by Considering Immunogenic Aspects of Cancer Stem Cells

SIMPLE SUMMARY: Modern radiotherapy offers several options for the treatment of brain metastases from breast cancer. The radioresistant subpopulation of cancer stem cells (CSCs) pose a particular challenge to a complete cure. This is attributable to the enhanced activation of molecular defense mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hintelmann, Katharina, Petersen, Cordula, Borgmann, Kerstin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818478/ https://www.ncbi.nlm.nih.gov/pubmed/36612206 http://dx.doi.org/10.3390/cancers15010211

Ejemplares similares

Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
por: Lee, Sungmin, et al.
Publicado: (2018)

Das BRCA-like-Mammakarzinom profitiert von Cisplatin plus Veliparib; Ergebnisse der S1416-Phase-II-Studie
por: Hintelmann, Katharina, et al.
Publicado: (2023)

Clinical practice guideline on the optimal radiotherapeutic management of brain metastases
por: Tsao, May N, et al.
Publicado: (2005)

Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer
por: Choe, Kevin S., et al.
Publicado: (2010)

Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients
por: Im, Jung Ho, et al.
Publicado: (2015)

Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases
por: Khan, Muhammad, et al.
Publicado: (2020)

Efficient DNA Repair Mitigates Replication Stress Resulting in Less Immunogenic Cytosolic DNA in Radioresistant Breast Cancer Stem Cells
por: Meyer, Felix, et al.
Publicado: (2022)

Integrin Targeted Delivery of Radiotherapeutics
por: Liu, Zhaofei, et al.
Publicado: (2011)

Regulatory T Cells in Radiotherapeutic Responses
por: Schaue, Dörthe, et al.
Publicado: (2012)

Utilization Patterns of Single-Fraction and Short-Course Radiotherapeutic Schedules in the Management of Bone Metastases
por: Koduri, Sravya, et al.
Publicado: (2023)

Müllerian duct anomalies and their effect on the radiotherapeutic management of cervical cancer
por: Rastogi, Madhup, et al.
Publicado: (2013)

Survival Disparities in the Radiotherapeutic Management of Lung Cancer by Regional Poverty Level
por: Mahase, Sean, et al.
Publicado: (2018)

Nanoradiosensitizer with good tissue penetration and enhances oral cancer radiotherapeutic effect
por: Jing, Di, et al.
Publicado: (2022)

Patterns of lymph node metastases and their implications in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with endometrial cancer
por: Teng, Fei, et al.
Publicado: (2022)

Radiotherapeutic management of brain tumours during the COVID-19 pandemic
por: Balakrishnan, Rajesh, et al.
Publicado: (2020)

The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients
por: Zheng, Si-Yue, et al.
Publicado: (2023)

Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors
por: Classen, Sandra, et al.
Publicado: (2023)

Radiotherapeutic alternatives for previously irradiated recurrent gliomas
por: Combs, Stephanie E, et al.
Publicado: (2007)

STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
por: Yang, Ping-Lian, et al.
Publicado: (2020)

Radiotherapeutic Management of Synchronous Prostate and Rectal Cancers Using Proton Beam Therapy
por: Chiang, Jennifer S., et al.
Publicado: (2021)

Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients
por: Zhang, Ran, et al.
Publicado: (2022)

Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers
por: Bryan, Sarah, et al.
Publicado: (2021)

Radiotherapeutic treatment options for oligotopic malignant liver lesions
por: Wust, Peter, et al.
Publicado: (2021)

Radiotherapeutic management of cervical lymph node metastases from an unknown primary site – experiences from a large cohort treated with modern radiation techniques
por: Sprave, Tanja, et al.
Publicado: (2020)

Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
por: Keeling, A. A., et al.
Publicado: (1989)

Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT)
por: Combs, Stephanie E, et al.
Publicado: (2006)

Pulmonary toxicity generated from radiotherapeutic treatment of thoracic malignancies
por: Deng, Guodong, et al.
Publicado: (2017)

Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals
por: Wüstemann, Till, et al.
Publicado: (2016)

(211)At-labeled immunoconjugate via a one-pot three-component double click strategy: practical access to α-emission cancer radiotherapeutics
por: Fujiki, Katsumasa, et al.
Publicado: (2018)

Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
por: Dreher, Constantin, et al.
Publicado: (2017)

Monitoring Radiotherapeutic Response in Prostate Cancer Patients Using High Throughput FTIR Spectroscopy of Liquid Biopsies
por: Medipally, Dinesh K.R., et al.
Publicado: (2019)

LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer
por: Wang, You-hong, et al.
Publicado: (2021)

p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment
por: Krishnaraj, Jayaraman, et al.
Publicado: (2023)

Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment
por: Dinapoli, Loredana, et al.
Publicado: (2021)

Machine Learning-Based Radiomics Predicts Radiotherapeutic Response in Patients With Acromegaly
por: Fan, Yanghua, et al.
Publicado: (2019)

Distribution pattern of lymph node metastases and its implication in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with stage IA to IIA cervical cancer
por: Li, Xinglan, et al.
Publicado: (2015)

Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy
por: Mahantshetty, Umesh, et al.
Publicado: (2019)

[(177)Lu]Lu-PSMA-617 (Pluvicto(TM)): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2022)

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2015)

An approximate analytical solution of the Bethe equation for charged particles in the radiotherapeutic energy range
por: Grimes, David Robert, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1brma741mtgos1g8h1k9lc4p6b